Arabinoxylan

Arabinoxylan/Drug Interactions:

  • Cancer therapyCancer therapy: Clinical experience of some scientists suggests that MGN-3 may be safely and advantageously used in conjunction with conventional treatment, including chemotherapy and radiation, both to increase the cytotoxic effect of the therapy and to decrease adverse side effects (8).
  • Hypoglycemic drugs, insulinHypoglycemic drugs, insulin: Arabinoxylan may reduce blood sugar levels, according to a clinical trial (7).
  • ImmunnosuppressantsImmunnosuppressants: Manufacturers propose that arabinoxylan may possess immuno-stimulant properties. However, there is limited supporting evidence in this area.

    • Arabinoxylan/Herb/Supplement Interactions:

  • CalciumCalcium: Preparations of MGN-3 (BioBran?) arabinoxylan product contains unclear amounts of calcium.
  • Hypoglycemic herbs and supplementsHypoglycemic herbs and supplements: Arabinoxylan may reduce blood sugar levels, according to a clinical trial (7).
  • ImmunosuppressantsImmunosuppressants: Manufacturers propose that arabinoxylan may possess immuno-stimulant properties. However, there is limited supporting evidence in this area.
  • PhosphorusPhosphorus: Preparations of MGN-3 (BioBran?) arabinoxylan product contains unclear amounts of phosphorus.

    • Arabinoxylan/Food Interactions:

  • Insufficient available evidence.

    • Arabinoxylan/Lab Interactions:

  • Serum calciumSerum calcium: Preparations of MGN-3 (BioBran?) arabinoxylan product contains unclear amounts of calcium.
  • Serum glucoseSerum glucose: Arabinoxylan may reduce blood sugar levels, according to a clinical trial (7).
  • Serum phosphorusSerum phosphorus: Preparations of MGN-3 (BioBran?) arabinoxylan product contains unclear amounts of phosphorus.